SCHEMBL759462

SCHEMBL759462

O=C(O)CCC(=O)c1cccs1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.84
LMNA P02545 2/20 0.84
MEN1 O00255 2/20 0.84
KMT2A Q03164 2/20 0.84
NPC1 O15118 2/20 0.84
RAB9A P51151 2/20 0.84
POLB P06746 1/20 0.84
HPGD P15428 4/20 0.77
L3MBTL1 Q9Y468 2/20 0.61
PKM P14618 1/20 0.61
TSHR P16473 1/20 0.61
MAPK1 P28482 1/20 0.61
HTT P42858 1/20 0.61
HSD17B10 Q99714 1/20 0.61
CTNNB1 P35222 5/20 0.60
WNT3A P56704 4/20 0.60
GSK3B P49841 1/20 0.60
ERCC5 P28715 1/20 0.59
FEN1 P39748 1/20 0.59
DAO P14920 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1373347 0.98 ALDH1A1 (0.81) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL2216212 0.92 ALDH1A1 (1.00) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL5179130 0.89 HPGD (0.90) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL2415331 0.89 HPGD (0.96) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL5179083 0.87 HPGD (1.00) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL3383085 0.87 HPGD (1.00) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL9466891 0.85 HPGD (0.63) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL15979661 0.85 ALDH1A1 (0.78) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL22721189 0.83 ALDH1A1 (0.83) ALDH1A1LMNAMEN1KMT2ANPC1
SCHEMBL18755474 0.82 ALDH1A1 (0.81) ALDH1A1LMNAMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11884628-B2 Method for synthesizing lactam derivatives without use of catalyst GUIZHOU UNIVERSITY (CN) 2024-01-30 US claimed
US-20220177429-A1 METHOD FOR SYNTHESIZING LACTAM DERIVATIVES WITHOUT USE OF CATALYST GUIZHOU UNIVERSITY (CN) 2022-06-09 US claimed
WO-2020228170-A1 CATALYST-FREE SYNTHESIS METHOD FOR LACTAM DERIVATIVE 贵州大学 2020-11-19 WO claimed
CN-109942473-B Method for synthesizing lactam derivative without catalyst 贵州大学 2020-09-15 CN claimed
CN-109942473-A A kind of method of catalyst-free synthesis lactam derivatives 贵州大学 2019-06-28 CN claimed
US-7691889-B2 Antimycobacterial compounds LUPIN LIMITED (IN) 2010-04-06 US claimed
EP-1377589-B1 OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS PHARMACIA ITALIA SPA (IT) 2005-09-07 EP claimed
US-20050192275-A1 Novel antimycobacterial compounds LUPIN LIMITED (IN) 2005-09-01 US claimed
US-20050171346-A1 Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation AVENTIS PHARMA S.A. (FR) 2005-08-04 US claimed
WO-2004026848-A1 OXAZOLIDINONE DERIVATIVES, PROCESS FOR THEIR PREPERATION AND THEIR USE AS ANTIMYCOBACTERIAL AGENTS LUPIN LIMITED (IN) 2004-04-01 WO claimed
CN-115894434-B Preparation method of 4-piperazinyl benzothiophene hydrochloride 山东厚德精诚药业有限公司 2024-10-08 CN disclosed
US-11884628-B2 Method for synthesizing lactam derivatives without use of catalyst GUIZHOU UNIVERSITY (CN) 2024-01-30 US disclosed
CN-115894434-A Preparation method of 4-piperazinyl benzothiophene hydrochloride 山东厚德精诚药业有限公司 2023-04-04 CN disclosed
US-20220177429-A1 METHOD FOR SYNTHESIZING LACTAM DERIVATIVES WITHOUT USE OF CATALYST GUIZHOU UNIVERSITY (CN) 2022-06-09 US disclosed
US-11269251-B2 Resist composition and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-03-08 US disclosed
US-4096155-A ANIMAL GROWTH PROMOTERS AMERICAN CYANAMID COMPANY (US) 1978-06-20 US disclosed
US-4075228-A INTERMEDIATES FOR ANIMAL GROWTH PROMOTERS AMERICAN CYANAMID COMPANY (US) 1978-02-21 US disclosed
US-4058529-A Polycyclic amino derivatives of pyrrolidone and piperidone CIBA-GEIGY CORPORATION (US) 1977-11-15 US disclosed
US-4055644-A CNS DEPRESSANTS SANDOZ, INC. (US) 1977-10-25 US disclosed
US-3931176-A CNS DEPRESSANT SANDOZ INC. (US) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11884628-B2 Method for synthesizing lactam derivatives without use of catalyst COASY, SI, NAAA ALDH1A1 1960/4885LMNA 3590/4885MEN1 1464/4885
US-20220177429-A1 METHOD FOR SYNTHESIZING LACTAM DERIVATIVES WITHOUT USE OF CATALYST COASY, SI, NAAA ALDH1A1 1960/4885LMNA 3590/4885MEN1 1464/4885
US-20050171346-A1 Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation HEXD, CDK5, CHUK ALDH1A1 454/4885LMNA 2840/4885MEN1 1864/4885
US-20050192275-A1 Novel antimycobacterial compounds MDH1, IMMT, MLYCD ALDH1A1 1995/4885LMNA 3191/4885MEN1 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.